Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts
The second-generation antipsychotic clozapine is used as a medication for treatment-resistant schizophrenia. It has previously been associated with epigenetic changes in pre-clinical rodent models and cross-sectional studies of treatment-resistant schizophrenia. Cross-sectional studies are susceptib...
Main Authors: | Gillespie, AL, Walker, EM, Hannon, E, McQueen, GA, Sendt, K, Avila, A, Lally, J, Okhuijsen-Pfeifer, C, van der Horst, M, Hasan, A, Dempster, EL, Burrage, J, Bogers, J, Cohen, D, Boks, MP, Collier, DA, Egerton, A, Luykx, JJ, Mill, J, MacCabe, JH |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature [academic journals on nature.com]
2024
|
Similar Items
-
Biological predictors of clozapine response: a systematic review
by: Samanaite, R, et al.
Published: (2018) -
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow
by: Sun, J, et al.
Published: (2024) -
Sudden-onset catatonia following Clozapine withdrawal: a case report
by: Koychev, I, et al.
Published: (2016) -
Developing a validated methodology for identifying clozapine treatment periods in electronic health records
by: Segev, A, et al.
Published: (2024) -
COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine
by: Govind, R, et al.
Published: (2022)